New Guidelines Recommend Medications for Weight Loss to Prevent Heart Disease in US

A new study by the American College of Cardiology recommends that millions of Americans take weight-loss medications to prevent heart disease. The study suggests that exercise and healthy diet alone may not be enough to maintain heart health. Medications like Wegovy and Zepbound should be considered primary treatments for preventing heart disease, which is the leading cause of death in the US. The study aims to improve access to these treatments by influencing insurance companies and federal programs to cover them.

A recent study by the American College of Cardiology (ACC) has sparked significant interest in the use of weight-loss medications to prevent heart disease. The study, published in the journal JAMA Network Open, recommends that millions of Americans consider taking medications such as Wegovy and Zepbound as primary treatments to maintain heart health. The study suggests that while exercise and a healthy diet are essential, they may not be sufficient on their own to prevent heart disease, which remains the leading cause of death in the United States [2].

The study highlights the growing demand for effective weight management solutions. According to GoodRx data, the number of patients receiving Wegovy has doubled, while those receiving Zepbound have tripled since January 2024 [2]. Despite the high costs and limited insurance coverage, Americans are increasingly seeking these medications to manage their weight and improve their overall health.

HealthRX, a U.S.-based digital health platform, has recently expanded its online experience to include access to GLP-1 medications such as Ozempic, Zepbound, and compounded alternatives [1]. The platform offers a streamlined process for adults to explore medically appropriate weight loss options from the comfort of their homes. HealthRX facilitates access to these medications through a three-step intake process, which includes a clinical questionnaire, virtual consultation with a board-certified physician, and secure prescription delivery.

The platform emphasizes convenience and flexibility, removing the need for in-person consultations or insurance requirements. HealthRX also offers a suite of wellness support tools, including coaching support, educational resources, medication reminders, and outcome tracking, to reinforce adherence and increase long-term success [1].

The study by the ACC aims to influence insurance companies and federal programs to cover these medications, making them more accessible to a broader range of patients. The study suggests that increasing access to these treatments could significantly impact the number of heart disease cases and deaths in the United States.

References:
[1] https://www.globenewswire.com/news-release/2025/06/20/3102506/0/en/HealthRX-Expands-Telehealth-Website-Experience-to-Include-GLP-1-Weight-Loss-Solutions-Prescription-Access-and-24-7-Wellness-Support.html
[2] https://qz.com/ozempic-wegovy-zepbound-grail-1851714968